Document Detail

Nizatidine in the short-term treatment of duodenal ulcer--an Italian Multicenter Study.
MedLine Citation:
PMID:  2892768     Owner:  NLM     Status:  MEDLINE    
One hundred and seventy three patients suffering from duodenal ulcer, were selected for a double-blind, controlled and randomized parallel multicenter study, with interval endoscopic examinations. This study was undertaken to compare the efficacy and safety of nizatidine administered at a single dose (300 mg "nocte") versus ranitidine (300 mg "nocte") in the treatment of acute duodenal ulcer. One hundred and sixty five patients were found to meet every admission criterion and completed the study (86 on nizatidine and 79 on ranitidine). On admission to the study, both groups were seen to have been correctly selected and epidemiologically well-distributed as to history of duodenal ulcer, previous treatments and pre-study symptoms. The ulcer was considered healed when complete re-epithelialization had occurred in areas of ulcerated mucosa. Healing rates of duodenal ulcer proved to be globally similar in the two groups, both in the 4th week (nizatidine, 78%; ranitidine, 78%) and in the 8th week (nizatidine, 91%; ranitidine, 95%). After four weeks of treatment, 67% of the patients treated with nizatidine no longer had any symptoms, while 87% patients no longer suffered from day pain, and 91% had no nocturnal pain. As a result, intake of antacids quickly decreased during the first four weeks. A similar response was observed in the group receiving ranitidine. After administration at a single dose of 300 mg in the evening, nizatidine proved to be at least as effective and safe as 300 mg of ranitidine administered in the same way, with respect both to ulcer healing and symptom response.
E Bovero; M Poletti; A Boero; B C Mura; E Camarri; P Corradini; G Corsini; G Federici; M Curzio; G Gianquinto
Related Documents :
1978478 - Safety evaluation in both short- and long-term treatment of schizophrenia with remoxipr...
20586518 - Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole...
2735328 - A maintenance regimen of sucralfate 2 g at night for reduced relapse rate in duodenal u...
11597378 - Double-blind, placebo-controlled cross-over study of oral pilocarpine for the preventio...
12944158 - Reduced pain after surgery for cervical disc protrusion/stenosis: a 2 year clinical fol...
21264198 - Gender differences in the functional recovery after acute stroke.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Hepato-gastroenterology     Volume:  34     ISSN:  0172-6390     ISO Abbreviation:  Hepatogastroenterology     Publication Date:  1987 Dec 
Date Detail:
Created Date:  1988-03-02     Completed Date:  1988-03-02     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8007849     Medline TA:  Hepatogastroenterology     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  269-71     Citation Subset:  IM    
Divisione di Gastroenterologia, Ospedale S. Martino, Genova.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Trials as Topic
Duodenal Ulcer / drug therapy*
Histamine H2 Antagonists
Middle Aged
Ranitidine / adverse effects,  therapeutic use
Thiazoles / adverse effects,  therapeutic use*
Reg. No./Substance:
0/Histamine H2 Antagonists; 0/Thiazoles; 66357-35-5/Ranitidine; 76963-41-2/Nizatidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cardiovascular characterization of the DA2 dopamine receptor agonist quinpirole in rats.
Next Document:  Pancreatic hormones disappearance after total pancreatectomy in the duck: correlation between plasma...